Journal article · 2018 · Open access

Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe

Jacoline C. Bouvy, Claudine Sapède, Sarah E. Garner

Frontiers in Pharmacology, 9, 280 · Published 27 March 2018 · DOI 10.3389/fphar.2018.00280

Open PDFView at the publisherCite this paper

In brief

“Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe” is a 2018 journal article by Jacoline C. Bouvy and 2 co-authors, published in Frontiers in Pharmacology. OpenAlex counts 83 citations as of 19 November 2026, which puts it in the top 4% of works published in 2018 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Pharmacology.

Citations
83
Most cited in
2020 (18)
Field-weighted impact
13.49
References
23
Authors
3

Abstract

As per the EMA definition, adaptive pathways is a scientific concept for the development of medicines which seeks to facilitate patient access to promising medicines addressing high unmet need through a prospectively planned approach in a sustainable way. This review reports the findings of activities undertaken by the ADAPT-SMART consortium to identify enablers and explore the suitability of managed entry agreements for adaptive pathways products in Europe. We found that during 2006-2016 outcomes-based managed entry agreements were not commonly used for products with a conditional marketing authorization or authorized under exceptional circumstances. The barriers and enablers to develop workable managed entry agreements models for adaptive pathways products were discussed through interviews and a multi-stakeholder workshop with a number of recommendations made in this paper.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bouvy, J. C., Sapède, C., & Garner, S. E. (2018). Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe. Frontiers in Pharmacology, 9, 280. https://doi.org/10.3389/fphar.2018.00280

MLA 9

Bouvy, Jacoline C., et al. “Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe.” Frontiers in Pharmacology, vol. 9, 2018, p. 280. https://doi.org/10.3389/fphar.2018.00280.

Chicago

Bouvy, Jacoline C., Claudine Sapède, and Sarah E. Garner. 2018. “Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe.” Frontiers in Pharmacology 9: 280. https://doi.org/10.3389/fphar.2018.00280.

Harvard

Bouvy, J. C., Sapède, C. and Garner, S. E. (2018) ‘Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe’, Frontiers in Pharmacology, 9, p. 280. doi:10.3389/fphar.2018.00280.

IEEE

J. C. Bouvy, C. Sapède, and S. E. Garner, “Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe,” Frontiers in Pharmacology, vol. 9, p. 280, 2018, doi: 10.3389/fphar.2018.00280.

BibTeX

@article{bouvy2018managed,
  title     = {{Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe}},
  author    = {Bouvy, Jacoline C. and Sapède, Claudine and Garner, Sarah E.},
  journal   = {Frontiers in Pharmacology},
  year      = {2018},
  volume    = {9},
  pages     = {280},
  doi       = {10.3389/fphar.2018.00280},
  url       = {https://doi.org/10.3389/fphar.2018.00280}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201844
20191111
20201818
20211212
202288
202399
202499
202577
202655

Its field-weighted citation impact is 13.49: it has been cited 13.49 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy

  • managed entry agreements
  • adaptive pathways
  • conditional marketing authorisation
  • drug regulation
  • access to medicines
  • unmet medical needs
  • barriers and facilitators

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Bouvy, J. C., Sapède, C., & Garner, S. E. (2018). Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe. Frontiers in Pharmacology, 9, 280. https://doi.org/10.3389/fphar.2018.00280

How many times has this paper been cited?

83 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Pharmacology: sign in and open the PDF from this page.

Who wrote this paper?

Jacoline C. Bouvy, Claudine Sapède, Sarah E. Garner.

What is the DOI of this paper?

10.3389/fphar.2018.00280, permanently at https://doi.org/10.3389/fphar.2018.00280. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.